抗血栓治疗中的新策略:向血栓形成,同时保持血静
Martha M S Sim1,2, Semekidus Shiferawe2, Jeremy P Wood1,2,3
1Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, United States.
Frontiers in cardiovascular medicine
|November 8, 2023
概括
新的抗血栓治疗旨在防止血栓形成,而不会增加出血风险. 这些先进的治疗方法针对特定的途径,为抗血栓治疗提供了更安全的方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 心血管医学 心血管医学
背景情况:
- 抗血栓治疗平衡了凝块预防与出血风险.
- 目前的抗血小板和抗凝药需要谨慎管理,并携带固有的出血并发症.
- 最近在血小板和凝血系统方面的发现有可能降低出血风险.
研究的目的:
- 审查当前抗血栓治疗的现状.
- 讨论针对新的或现有的途径的新型抗血栓药物.
- 探索用于逆转直接口服抗凝剂的策略.
主要方法:
- 关于传统和新兴抗血栓治疗的文献综述.
- 对针对血小板和凝固系统的新药开发的分析.
- 对抗凝血剂逆转剂及其临床应用的研究.
主要成果:
- 在血栓形成和血液静止中确定新的治疗点.
- 开发下一代抗血栓剂,具有潜在的安全性.
- 与抗凝药相关的出血并发症管理策略的进展.
结论:
- 新兴的抗血栓疗法在分离静血和血栓功能方面表现有前途.
- 这些创新更接近于在没有同时出现出血风险的情况下实现凝块预防.
- 该领域正在朝着更安全,更有效的抗血栓治疗模式前进.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
719
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
535
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
535
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K


